Brooklyn Hospital Center

GHX Honors Top-Performing Healthcare Providers with 2023 Supply Chains of Distinction Award

Retrieved on: 
Tuesday, March 5, 2024

LOUISVILLE, Colo., March 5, 2024 /PRNewswire/ -- Global Healthcare Exchange (GHX) today announced the inaugural class of its Supply Chains of Distinction Award for 2023, which recognizes top performing hospitals and health systems in North America.

Key Points: 
  • LOUISVILLE, Colo., March 5, 2024 /PRNewswire/ -- Global Healthcare Exchange (GHX) today announced the inaugural class of its Supply Chains of Distinction Award for 2023, which recognizes top performing hospitals and health systems in North America.
  • Industry-leading supply chains have evolved to become more automated, data-driven and resilient, giving rise to a set of best practice "perfect order" metrics that measure an organization's supply chain performance.
  • The Supply Chains of Distinction Award honors GHX Exchange-connected provider organizations that excelled in driving best-in-class supply chain operations.
  • The following organizations represent the class of 2023 Supply Chains of Distinction Award recipients.

Targeted Oncology™ announces recipients of its Oncology Icons award program

Retrieved on: 
Wednesday, November 15, 2023

CRANBURY, N.J., Nov. 15, 2023 (GLOBE NEWSWIRE) -- Targeted Oncology™, a multimedia resource that offers engaging content and expert opinions on standard and emerging treatments in the field of oncology, is thrilled to announce the distinguished recipients of the prestigious Oncology Icons award program.

Key Points: 
  • CRANBURY, N.J., Nov. 15, 2023 (GLOBE NEWSWIRE) -- Targeted Oncology™, a multimedia resource that offers engaging content and expert opinions on standard and emerging treatments in the field of oncology, is thrilled to announce the distinguished recipients of the prestigious Oncology Icons award program.
  • This program recognizes individuals who have made exceptional contributions to the field of oncology through their expertise, dedication and innovation.
  • “We are honored to acknowledge the outstanding contributions of these Oncology Icons,” said Erik Lohrmann, senior vice president of, oncology and urology.
  • Submissions for the Oncology Icons award program are accepted on a rolling basis throughout the year.

TEXAS CHILDREN'S HOSPITAL CENTER FOR VACCINE DEVELOPMENT TEAM RECEIVES 2023 DAVID AND BEATRIX HAMBURG AWARD FOR VACCINE TECHNOLOGY DEVELOPMENT

Retrieved on: 
Thursday, September 28, 2023

HOUSTON, Sept. 28, 2023 /PRNewswire/ -- Texas Children's Hospital is pleased to announce that the Texas Children's Hospital Center for Vaccine Development team has been awarded the 2023 David and Beatrix Hamburg Award for their development of a recombinant protein-based COVID-19 vaccine technology, created in Houston, which has benefited millions of people around the world.

Key Points: 
  • HOUSTON, Sept. 28, 2023 /PRNewswire/ -- Texas Children's Hospital is pleased to announce that the Texas Children's Hospital Center for Vaccine Development team has been awarded the 2023 David and Beatrix Hamburg Award for their development of a recombinant protein-based COVID-19 vaccine technology, created in Houston, which has benefited millions of people around the world.
  • "This recognition reinforces the importance of fostering exceptional, creative and interdisciplinary scientific teams to advance biomedical sciences that benefit humanity."
  • In India, the vaccine is produced under the name Corbevax by Biological E. Limited.
  • Botswana has also approved Corbevax and the Texas Children's team is further assisting with vaccine development capacity in Africa through a training program for scientists.

Assertio Holdings, Inc. Closes Spectrum Pharmaceuticals Transaction

Retrieved on: 
Tuesday, August 1, 2023

LAKE FOREST, Ill., July 31, 2023 (GLOBE NEWSWIRE) -- Assertio Holdings, Inc. (“Assertio” or the “Company”) (Nasdaq: ASRT), a specialty pharmaceutical company offering differentiated products to patients, today announced that it has closed the proposed acquisition of Spectrum Pharmaceuticals, Inc. (“Spectrum”) (Nasdaq: SPPI), a biopharmaceutical company focused on novel and targeted oncology.

Key Points: 
  • LAKE FOREST, Ill., July 31, 2023 (GLOBE NEWSWIRE) -- Assertio Holdings, Inc. (“Assertio” or the “Company”) (Nasdaq: ASRT), a specialty pharmaceutical company offering differentiated products to patients, today announced that it has closed the proposed acquisition of Spectrum Pharmaceuticals, Inc. (“Spectrum”) (Nasdaq: SPPI), a biopharmaceutical company focused on novel and targeted oncology.
  • Assertio intends to provide updated guidance for the combined business as part of its second quarter results call on August 3.
  • He also serves on the board of directors of Annexus Health, Spectrum Pharmaceuticals, OneOncology, and the American Red Cross of Greater New York.
  • Dr. Vacirca also received the Theodore Roosevelt Award for outstanding dedication to patient care and was named Newsday's Top Doctor.

Bassem Elmankabadi, M.D. joins Foresee Pharmaceuticals as a Senior Vice President of Clinical Development

Retrieved on: 
Monday, April 17, 2023

TAIPEI, April 17, 2023 /PRNewswire/ -- Foresee Pharmaceuticals Co., Ltd. (6576.TWO) ("Foresee"), announces today that Bassem Elmankabadi, M.D.

Key Points: 
  • TAIPEI, April 17, 2023 /PRNewswire/ -- Foresee Pharmaceuticals Co., Ltd. (6576.TWO) ("Foresee"), announces today that Bassem Elmankabadi, M.D.
  • joins Foresee as a Senior Vice President of Clinical Development.
  • Dr. Bassem Elmankabadi is a Board Certified Surgeon with over 17 years of clinical background and experience in the pharmaceutical industry, including multiple clinical leadership roles at Amgen (NASDAQ: AMGN), FibroGen (NASDAQ: FGEN), and Blade Therapeutics.
  • "We are thrilled to have Dr. Elmankabadi join our team," said Dr. Ben Chien, Chairman and CEO of Foresee Pharmaceuticals.

Gary S. Saphire, DPM, FACFAS is recognized by Continental Who's Who

Retrieved on: 
Thursday, December 22, 2022

BROOKLYN, N.Y., Dec. 22, 2022 /PRNewswire/ -- Gary S. Saphire, DPM, FACFAS, is being recognized by Continental Who's Who as a Trusted Healthcare Professional for his work in the Medical field and his private practice at Parkway Podiatry.

Key Points: 
  • BROOKLYN, N.Y., Dec. 22, 2022 /PRNewswire/ -- Gary S. Saphire, DPM, FACFAS, is being recognized by Continental Who's Who as a Trusted Healthcare Professional for his work in the Medical field and his private practice at Parkway Podiatry.
  • He is board-certified in foot and ankle surgery and rear-front reconstructive surgery, as well as quality assurance and utilization review.
  • Dr. Saphire has practiced medicine for more than 40 years and specializes in performing successful foot and ankle surgery.
  • He has served as the Director of Foot and Ankle Surgery at both the Brooklyn Hospital Center and Caledonian Hospital.

Mental Health Expert Dr. Mike Hoaglin Joins Exclusive Haute MD Network

Retrieved on: 
Saturday, December 17, 2022

OAKLAND, Calif., Dec. 17, 2022 /PRNewswire-PRWeb/ -- Dr. Mike Hoaglin, MD is a psychiatrist and trained physician who practices virtually and in person. Dr. Mike is the founder and medical director of Gut Feelings Psychosomatic Medicine. Dr. Mike graduated from Northwestern University with dual biomedical and electrical engineering degrees. He graduated from the Perelman School of Medicine at the University of Pennsylvania and received residency training from Duke University Hospital and Brooklyn Hospital Center.

Key Points: 
  • Dr. Mike Hoaglin joins Haute MD Network as a mental health expert representing the Oakland, CA market.
  • OAKLAND, Calif., Dec. 17, 2022 /PRNewswire-PRWeb/ -- Dr. Mike Hoaglin, MD is a psychiatrist and trained physician who practices virtually and in person.
  • Dr. Mike takes a precision approach to mental health care using validated assessments, frequent communication, and specialized testing so patients can see objective improvement and feel better sooner.
  • For more about Haute Beauty/MD, visit https://hauteliving.com/hautebeauty/
    Brooke Klaiman, Haute Beauty by Haute Living, 5612122126, [email protected]

Dr. Maria Elena Bottazzi and Dr. Flor Muñoz Receive the Houston Mayor's 2022 Hispanic Heritage Award in Healthcare

Retrieved on: 
Tuesday, October 11, 2022

HOUSTON, Oct. 11, 2022 /PRNewswire/ -- Two innovative Houstonians with Texas Children's Hospital and Baylor College of Medicine received the Mayor's 2022 Hispanic Heritage Award in healthcare today. Dr. Maria Elena Bottazzi, co-director of the Texas Children's Hospital Center for Vaccine Development and professor and associate dean of the National School of Tropical Medicine at Baylor College of Medicine, and Dr. Flor Muñoz, director of transplant infectious diseases at Texas Children's Hospital and an associate professor of pediatrics – infectious diseases at Baylor College of Medicine, officially received the award jointly during a proclamation ceremony today at City Hall.

Key Points: 
  • HOUSTON, Oct. 11, 2022 /PRNewswire/ -- Two innovative Houstonians with Texas Children's Hospital and Baylor College of Medicine received the Mayor's 2022 Hispanic Heritage Award in healthcare today.
  • Dr. Bottazzi has led numerous community events to educate Latinos about COVID-19 vaccine development and served on local and national task forces.
  • "I am honored and humbled to receive, jointly with Dr. Muoz, this award and celebrate our Central American heritage.
  • "It is a true honor to receive the Mayor's Hispanic Heritage Award for Healthcare along with Dr. Bottazzi.

Global Genes and Rare Disease Diversity Coalition Launch Next Phase of Multifaceted Partnership Aimed at Accelerating and Advancing Health Equity

Retrieved on: 
Thursday, October 6, 2022

Global Genes , a leading rare disease patient advocacy organization, and the Rare Disease Diversity Coalition (RDDC) today launched the next phase of a multifaceted partnership to accelerate and advance health equity for the rare disease community.

Key Points: 
  • Global Genes , a leading rare disease patient advocacy organization, and the Rare Disease Diversity Coalition (RDDC) today launched the next phase of a multifaceted partnership to accelerate and advance health equity for the rare disease community.
  • It affords more equitable access to trials, treatments and care for underserved populations within the rare disease community.
  • Black Womens Health Imperative launched the Rare Disease Diversity Coalition to address the extraordinary challenges faced by rare disease patients of color.
  • The Rare Disease Diversity Coalition is focused on reducing racial disparities in the rare disease community.

Dr. Peter Hotez and Dr. Maria Elena Bottazzi Named Two of Fast Company's 2022 Most Creative People in Business

Retrieved on: 
Tuesday, August 9, 2022

HOUSTON, Aug. 9, 2022 /PRNewswire/ -- Fast Company today announced its 14th annual list of the Most Creative People in Business, which recognizes individuals making a cultural impact via bold achievements that have never been accomplished before in their chosen fields, from entertainment to healthcare to food. These influential and diverse engineers, executives, filmmakers, activists, designers, research scientists, and founders, among others, are leading with creativity during one of the most challenging times in history.

Key Points: 
  • Hotez and Bottazzi have been nominated for the 2022 Nobel Peace Prize for their research and vaccine development of COREBEVAX.
  • "Most Creative People represents Fast Company at its best," says Brendan Vaughan, Fast Company's Editor-in-Chief.
  • Introduced in 2009, the Most Creative People list quickly established itself as one of Fast Company'smost esteemed franchises.
  • Fast Company'sMost Creative People in Business issue (September 2022) is available online now here and on newsstands beginning August 16.